Semaglutide TFA (Ozempic, GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study

Cat No.: GMP-Bios-peptide-004

Product Name: Semaglutide TFA

Structural formula:

Picture loading failed.

Semaglutide TFA, the trifluoroacetic acid salt form of Semaglutide. Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medicationused for the treatment of type 2 diabetes and chronic weight management.



Order information

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-peptide-004-5mg 5mg 780
GMP-Bios-peptide-004-25mg 25mg 1950
GMP-Bios-peptide-004-50mg 50mg 2925
GMP-Bios-peptide-004-100mg 100mg 3900
GMP-Bios-peptide-004-500mg 500mg 7800
GMP-Bios-peptide-004-xmg ≥500mg Inquiry
Shipping Cost: 760.00
Total:

For more than 500mg, click here for inquiry. >>


Description

Product NameSemaglutide TFA
Brand nameOzempic
CAS No.910463-68-2 
FormulaC189H292F3N45O61
Biological ActivitySemaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion.
PurityPurity: ≥98% (HPLC)
ApplicationTherapeutic peptides drug benchmark or raw material for peptide drugs or peptide conjugation drugs discovery and development.
Predicted Molecular Mass4210.63
FormulationPowder
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.